Background: The authors examined the patterns of improvement in cognitive and
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy Although cognitive therapy (CT) and pharmacotherapy (PT) have been found to be similarly effective for treating major depression (DeRubeis et al., 1999; DeRubeis et al., 2005; Hollon et al., 2005) , there is little research on the sequence of symptom improvement for each of the treatment modalities. One possibility suggested in the literature is that cognitive symptoms of depression improve before vegetative symptoms when patients are treated with CT, with the reverse pattern implicated for PT (DiMascio et al., 1979; Rush et al., 1981) . Such distinct patterns of symptom remission are based on the theoretical assumptions underlying the different treatments (reviewed in Goldapple et al., 2004) . CT is assumed to directly target cognitive processes such as dysfunctional attitudes and negative automatic thoughts (Beck et al., 1988) , the improvement of which in turn would facilitate improvements in other symptoms of major depression.
Conversely PT involving serotonin selective reuptake inhibitors (SSRIs) alters serotonin functioning (Hyman and Nestler, 1996) known to play a key role in the regulation of appetite, sleep and several other vegetative functions. Thus, SSRIs may improve vegetative functions, before other symptoms of depression.
Empirical results have been inconsistent with respect to whether CT and PT are associated with distinct patterns of symptom improvement. Rush and colleagues (1981) found that across the first four weeks of treatment, CT was associated with initial improvements in hopelessness, self beliefs and negative mood followed by the alleviation of vegetative and motivational symptoms while no discernable pattern of change was seen in patients treated with PT. DiMascio and colleagues (1979) found that vegetative symptoms of depression such as sleep disturbance improved before depression, anxiety and apathy for patients treated with PT, a pattern not observed for patients treated with interpersonal psychotherapy. Further, Haskell, DiMascio and Prusoff (1975) found that PT was associated with rapid improvements in sleep, appetite disturbances and suicidal feelings, but slower improvement in cognitive and behavioral symptoms such as hopelessness, interest and retardation.
However, other studies have not found discernible treatment specific differences in the rapidity of change of vegetative or cognitive symptoms. DeRubeis and colleagues (DeRubeis et al., 1990) found that cognitive constructs associated with vulnerability of depression (e.g., hopelessness, dysfunctional assumptions) were significantly reduced in the first half of treatment, regardless of whether patients were treated with CT (alone, or in combination with PT) or PT alone. Similarly, Simons, Garfield and Murphy (1984) found that CT and PT were associated with nearly identical patterns of improvement in negative automatic thoughts and dysfunctional assumptions. Accordingly, Mandell (1988) found that cognitive and vegetative symptoms of depression changed in a uniform manner across CT and PT.
With the exception of research by Rush et al. (1981) and Mandell (1988) , researchers have not examined session-by-session changes in cognitive and vegetative symptoms of major depression in response to CT and to PT. Assessing symptoms over such short intervals is necessary to detect the pattern of change of symptoms over the course of treatment (DeRubeis et al., 1990; Laurenceau et al., 2007) . The purpose of this study, therefore, was to examine the pattern of improvement in cognitive versus vegetative symptoms of major depression as a function of the form of treatment in a sample in which symptoms were measured repeatedly and relatively frequently. 
Method

Measures and Procedures
Beck Depression Inventory -II (BDI-II: Beck et al., 1996 ) is a 21-item selfreport instrument measuring the severity of depression in adults and adolescents. Each item is rated on a 4-point scale ranging from 0 to 3 and possible total scores range from 0 to 63. Support for the validity and reliability of the BDI is well established with samples from various populations (Beck et al., 1996) . The items in the BDI have been found to segregate into two factors: nine items representing a cognitive dimension (e.g., pessimism, self-dislike, self criticalness) and twelve items representing a somaticaffective dimension (e.g., changes in sleeping patterns, changes in eating patterns, fatigue) of self-reported depression (Beck et al., 1996) . In the current study, unweighted means of the items assigned to each factor were used as measures of cognitive and vegetative symptoms of depression respectively (COG and VEG). The BDI-II was assessed at baseline (i.e., the earliest available BDI-II score ranging from 2 weeks prior to treatment) and at weeks 1, 2, 3, 4, 6, 8, 10, 12, 14, and 16 by the multivariate HLM model. There were no statistically significant differences between the linear or quadratic terms in the estimated change trajectories for COG and VEG in either of the treatment conditions (see Table 1 ). Visually, VEG appeared to improve more rapidly than COG between weeks -2 (two weeks prior to the start of treatment) and week 1 in the PT condition. Therefore, we conducted an additional test of the difference between the COG and VEG trajectories in PT between weeks -2 and 1 (using a random intercepts model without quadratic terms). This additional test did not achieve statistical significance (t =.27, df =290, p =.78). Overall, the trajectories of improvement were similar for COG and VEG in the CT condition, and in the PT condition. While inconsistent with some theory-driven expectations (Goldapple et al., 2004; Rush et al., 1981) , these results are consistent with Beck's (Beck, 1984, November) suggestion that vegetative and cognitive features of depression do not represent different systems of depression, but rather different levels of analyses of the same system. Beck suggests that the site of action of both PT and CT is the informational processing system, which, when targeted, results in changes in both cognitive and vegetative features of major depression. Our findings correspond with the proposal that although CT and PT may be associated with different primary mechanisms of change (DeRubeis et al., 1990; DeRubeis et al., 1999; DeRubeis et al., 2005; Goldapple et al., 2004; Hyman and Nestler, 1996) , these mechanisms serve to activate changes in the informational processing system, which in turn leads to uniform improvement across vegetative and cognitive dimensions of depression.
The outcomes of this study are consistent with past research that found vegetative and cognitive symptoms changed in unison in response to PT (Rush et al., 1981) or to a psychosocial treatment (DiMascio et al., 1979) . However, our findings are also discrepant from research showing that different patterns of improvement are evident in such symptoms in response to PT (DiMascio et al., 1979; Haskell et al., 1975) or CT (Rush et al., 1981) . The discrepant findings may be due to differences in how patterns of change were analyzed. Rush et al. conducted cross lagged correlations to determine which symptoms improved before others across the first four weeks of treatment. This method of analysis has been since criticized as inadequate for examining models of change and causality (Rogosa, 1980) . DiMascio et al. conducted a series of analyses of covariance to investigate significant differences between baseline scores of the HRSD and evaluations during treatment (week 1, 4, 8, 12 and 16) . However, they did not correct for family wise type 1 error rates, thereby allowing for an inflated chance of falsely rejecting the null hypotheses. In contrast, the current study used more appropriate analyses to investigate change trajectories of cognitive and vegetative symptoms (i.e., HLM), and controlled for inflated type 1 error rates.
The difference in findings may also relate to the different ways in which symptoms were defined and measured. Compared to the current study, previous researchers measured symptoms more specifically (e.g., sleep problems, appetite problems, negative self-views,) and examined problems that encompassed both vegetative and cognitive aspects (e.g., apathy, anxiety). For example, in order to measure the speed by which various symptoms changed in context of PT, Haskell and colleagues (1975) examined the change patterns of each item on a modified version of the HRSD. In the current study, we consolidated depressive symptoms as either vegetative or cognitive and measured these with established factors on the BDI-II. Given that Haskell et al.
found some vegetative features to change more quickly than others in PT, it is possible that certain symptoms change faster than others, but that this effect is not observed when symptoms are grouped into broad categories such as vegetative or cognitive.
Four issues related to this study can be addressed by further research. First, this study did not compare the trajectories of change of symptoms between patients in treatment and those not in treatment Researchers have suggested that antidepressant treatments activate a trajectory of improvement similar to that observed for patients not in active treatment (Stassen et al., 1993) . It is argued that antidepressant treatments simply increase the probability of, but not the trajectory of, improvement in depressive symptoms, compared to the course observed for untreated depression. Further research can examine whether both cognitive and vegetative dimensions of depression show similar trajectories of change for patients in active treatment versus those not in treatment for depression.
Second, given that patients receiving PT were provided clinical management which involved support and advice, it is important to further examine whether nonspecific factors play a role in influencing the pattern of response of symptoms to pharmacotherapy. Third, as it is a self-report measure, the BDI-II provides information about the participants' perceptions of their symptoms, rather than more objective indices of difficulties (e.g., hours of sleep, weight gain). Further research could investigate differences in the pattern of response of symptoms in CT and PT using observer-rated measures of depression such as the HRSD, or objective findings such as sleep lab reports.
Finally, both BDI-II factors included items measuring affect and behavior, which may have affected the validity with which the factors measured purely cognitive and vegetative symptoms respectively. Future research should include measures of individual symptoms such as negative mood or appetite problems, in order to examine divergent patterns of change in specific depressive symptoms.
